Genomenon

Genomenon is an AI-driven genomics company that makes genomic information actionable for patients with rare genetic diseases and cancer. Genomenon connects current research with patient DNA to accelerate clinical decision making and pharmaceutical drug discovery. With the use of SaaS modeling the company optimizes drug discovery and clinical trial target selection with an AI-driven genomic landscape for any disease and accelerate NGS variant interpretation with rapid search and insight into the full text of the genomic literature. The company's database Mastermind is a source for genomics literature.

Mastermind’s features and capabilities center on searching genes, diseases, and variants, following the company’s initial product positioning—supporting geneticists and molecular pathologists in their clinical genomic analyses for diagnostic purposes. The company recently added phenotypic searches to its engine capability and will be adding drug and therapeutic searches in the near term, strengthening its emerging expansion into the pharmaceutical market to advance personalized medicine.